Markets › India › NSE › JUBLPHARMA

Jubilant Pharmova Ltd

NSE:JUBLPHARMAHealthcareNSE:NIFTY_MICROCAP250NSE:NIFTY_TOTAL_MKT

₹935.80−0.30%At closeAt close · Mon 19 Oct · ≈ AED 36.16 · Market cap $1.58B · Next earnings Fri 30 Oct

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	74.8%	75.7%	66.9%	64.9%	64.9%	30.1%	—	—
Operating margin	42.9%	41.9%	31.6%	30.8%	32.6%	9.9%	9.9%	+0.0 pts
Net margin	13.7%	6.8%	−1.0%	1.2%	11.6%	4.8%	4.8%	+0.0 pts
EBITDA margin	24.1%	17.4%	10.3%	11.8%	14.5%	15.3%	—	—
Return on equity	17.6%	7.8%	−1.1%	1.4%	13.4%	5.6%	5.6%	−0.0 pts
Return on assets	9.4%	4.1%	−0.5%	0.7%	6.6%	2.6%	2.6%	+0.0 pts
Return on capital employed	33.3%	30.6%	21.2%	21.4%	22.2%	6.3%	—	—
Debt / equity	0.6×	0.6×	0.7×	0.7×	0.4×	0.5×	0.5×	−0.0%
Debt / assets	31.7%	31.9%	33.0%	31.7%	21.4%	23.3%	—	—
Interest coverage	14.2×	17.7×	10.5×	7.6×	9.8×	3.9×	—	—
Current ratio	2.8×	2.2×	2.1×	2.1×	1.7×	1.6×	1.6×	+0.0%
Quick ratio	1.7×	1.4×	1.3×	1.4×	1.1×	1.1×	—	—
Cash ratio	0.5×	0.6×	0.6×	0.5×	0.5×	0.5×	0.5×	+0.0%
Asset turnover	0.7×	0.6×	0.6×	0.6×	0.6×	0.5×	—	—
Inventory turnover	1.3×	1.2×	1.5×	1.8×	2.2×	4.7×	—	—
Receivables turnover	7.0×	5.4×	6.0×	5.4×	8.1×	7.7×	—	—
Dividend payout	0.2%	19.3%	−131.2%	103.5%	9.5%	19.9%	—	—